Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Wilson

Concepts (260)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pathology
7
2018
21
3.190
Why?
Clinical Laboratory Techniques
9
2019
96
2.890
Why?
Global Health
9
2025
403
2.410
Why?
Pathology, Clinical
5
2018
29
1.650
Why?
Diagnostic Techniques and Procedures
3
2023
19
1.530
Why?
Clinical Laboratory Services
3
2018
7
1.120
Why?
Laboratories
6
2022
109
0.980
Why?
Pathologists
2
2024
19
0.940
Why?
Autopsy
3
2014
96
0.840
Why?
Malaria
3
2014
73
0.790
Why?
Molecular Diagnostic Techniques
3
2015
104
0.780
Why?
Education, Medical
4
2015
274
0.740
Why?
Health Services Accessibility
4
2025
1107
0.730
Why?
Quality of Health Care
3
2018
702
0.660
Why?
Antitubercular Agents
2
2013
212
0.620
Why?
Internship and Residency
3
2015
1281
0.590
Why?
Communicable Diseases
3
2008
166
0.590
Why?
Health Services Needs and Demand
2
2018
287
0.570
Why?
Tuberculosis
2
2013
290
0.560
Why?
Mycobacterium tuberculosis
2
2013
325
0.560
Why?
Early Diagnosis
1
2019
251
0.530
Why?
Reimbursement Mechanisms
2
2015
79
0.520
Why?
Education, Medical, Continuing
2
2018
130
0.520
Why?
Pathology, Surgical
1
2017
6
0.500
Why?
Humans
61
2025
146342
0.490
Why?
Developing Countries
5
2021
312
0.490
Why?
Parasitemia
2
2013
15
0.480
Why?
Health Equity
1
2019
139
0.480
Why?
Calciphylaxis
1
2015
2
0.460
Why?
Search Engine
1
2015
13
0.450
Why?
Microbiology
1
2015
24
0.440
Why?
Diagnostic Tests, Routine
2
2017
109
0.440
Why?
Evidence-Based Medicine
1
2019
731
0.440
Why?
Health Services Misuse
1
2015
33
0.440
Why?
Malaria, Vivax
1
2014
4
0.430
Why?
Pathology, Molecular
1
2014
28
0.420
Why?
Antimalarials
1
2014
35
0.420
Why?
Malaria, Falciparum
1
2014
32
0.420
Why?
Efficiency
1
2015
102
0.410
Why?
Medical Laboratory Personnel
1
2014
6
0.410
Why?
Drug Resistance, Bacterial
3
2013
185
0.400
Why?
Artificial Intelligence
1
2018
389
0.390
Why?
Plasmodium
1
2013
12
0.390
Why?
Leiomyoma
1
2014
62
0.390
Why?
Reagent Kits, Diagnostic
1
2013
33
0.380
Why?
Uterine Neoplasms
1
2014
98
0.380
Why?
Diagnosis
2
2025
16
0.370
Why?
Neoplasms
3
2018
2954
0.360
Why?
Students, Medical
2
2014
383
0.350
Why?
Population Surveillance
2
2018
481
0.350
Why?
Cooperative Behavior
1
2014
471
0.330
Why?
Bacteriological Techniques
1
2011
66
0.330
Why?
Otitis Media
2
2024
178
0.330
Why?
United States Public Health Service
1
2010
8
0.320
Why?
Genomics
2
2019
853
0.310
Why?
Immunoassay
2
2011
108
0.310
Why?
Physicians
2
2015
955
0.290
Why?
Communication
1
2015
980
0.280
Why?
Community Health Services
1
2010
229
0.270
Why?
Influenza A Virus, H1N1 Subtype
1
2009
162
0.270
Why?
Referral and Consultation
1
2014
881
0.260
Why?
Health Personnel
1
2014
754
0.260
Why?
Soft Tissue Infections
1
2008
42
0.260
Why?
Bone Diseases
1
2008
60
0.250
Why?
Haemophilus influenzae
2
2024
67
0.250
Why?
Joint Diseases
1
2008
66
0.250
Why?
Microbiological Techniques
2
2008
30
0.250
Why?
Polymerase Chain Reaction
1
2009
1031
0.240
Why?
Latent Tuberculosis
2
2018
71
0.240
Why?
Biological Evolution
3
2025
471
0.240
Why?
Skin Diseases
1
2008
144
0.230
Why?
Government Agencies
1
2005
14
0.230
Why?
Forensic Pathology
1
2005
10
0.230
Why?
Health Facility Closure
1
2005
8
0.230
Why?
Vocalization, Animal
1
2025
28
0.220
Why?
Academies and Institutes
1
2005
61
0.220
Why?
Pan troglodytes
1
2025
62
0.220
Why?
Urinary Tract Infections
2
2004
209
0.210
Why?
Music
1
2025
43
0.210
Why?
Conjunctivitis, Bacterial
1
2024
12
0.210
Why?
Urine
1
2004
63
0.200
Why?
Amoxicillin
1
2024
35
0.200
Why?
Military Medicine
1
2005
148
0.200
Why?
Influenza, Human
1
2009
640
0.190
Why?
Armed Conflicts
1
2023
16
0.190
Why?
Meta-Analysis as Topic
2
2013
173
0.180
Why?
Sensitivity and Specificity
3
2013
1998
0.180
Why?
Rifampin
2
2013
80
0.170
Why?
Health Policy
1
2025
399
0.170
Why?
Isoniazid
2
2013
71
0.170
Why?
Microbial Sensitivity Tests
3
2013
367
0.170
Why?
World Health Organization
3
2020
104
0.170
Why?
Interferon-gamma Release Tests
2
2018
32
0.160
Why?
Logical Observation Identifiers Names and Codes
1
2020
1
0.160
Why?
Clinical Laboratory Information Systems
1
2020
4
0.160
Why?
Women's Health
2
2013
317
0.160
Why?
Levamisole
2
2011
22
0.160
Why?
Urban Population
3
2018
497
0.160
Why?
Gonorrhea
1
2021
63
0.150
Why?
Chlamydia Infections
1
2021
79
0.150
Why?
Point-of-Care Systems
2
2019
185
0.150
Why?
Cost of Illness
1
2022
323
0.150
Why?
Clinical Coding
1
2019
28
0.150
Why?
Papio
1
2019
71
0.150
Why?
Anti-Bacterial Agents
3
2024
1942
0.140
Why?
Cocaine
2
2011
162
0.140
Why?
Diagnostic Imaging
1
2021
340
0.140
Why?
Africa
3
2015
119
0.140
Why?
Behavior, Animal
2
2019
531
0.140
Why?
Insurance, Health, Reimbursement
1
2019
97
0.140
Why?
Socioeconomic Factors
2
2021
1327
0.140
Why?
Africa South of the Sahara
1
2018
56
0.130
Why?
Health Education
2
2018
346
0.130
Why?
Urban Health Services
1
2018
68
0.130
Why?
Social Behavior
1
2019
279
0.130
Why?
Infant
5
2024
10114
0.130
Why?
Leukemoid Reaction
1
2016
3
0.130
Why?
GATA1 Transcription Factor
1
2016
18
0.120
Why?
Acute Disease
3
2024
1038
0.120
Why?
Sexual and Gender Minorities
1
2021
269
0.120
Why?
Mass Screening
2
2018
1307
0.120
Why?
Diseases in Twins
1
2016
115
0.120
Why?
Public Health
2
2018
574
0.120
Why?
Point Mutation
1
2016
232
0.110
Why?
Clinical Audit
1
2015
14
0.110
Why?
Cost Control
1
2015
38
0.110
Why?
Utilization Review
1
2015
39
0.110
Why?
Human Activities
1
2015
19
0.110
Why?
Enterocolitis, Pseudomembranous
1
2015
29
0.110
Why?
Benchmarking
1
2016
193
0.110
Why?
Female
14
2025
79499
0.110
Why?
Immunologic Factors
1
2016
244
0.100
Why?
Medication Therapy Management
1
2015
73
0.100
Why?
Hominidae
1
2015
89
0.100
Why?
Plasmodium vivax
1
2014
6
0.100
Why?
Hospitals
1
2019
738
0.100
Why?
Drug Contamination
2
2011
56
0.100
Why?
Agranulocytosis
2
2011
30
0.100
Why?
Child, Preschool
5
2024
11913
0.100
Why?
Neoplasm Staging
1
2018
1488
0.100
Why?
Parasite Load
1
2013
10
0.100
Why?
Conservation of Natural Resources
1
2015
120
0.100
Why?
Antigens, Protozoan
1
2013
32
0.100
Why?
Infection Control
1
2015
174
0.100
Why?
Parasitology
1
2012
9
0.090
Why?
Adult
10
2021
41087
0.090
Why?
Anti-Infective Agents
1
2015
234
0.090
Why?
Cross Infection
1
2015
258
0.090
Why?
AIDS-Related Opportunistic Infections
1
2013
130
0.090
Why?
Time Factors
2
2013
7109
0.090
Why?
DNA, Bacterial
1
2013
319
0.090
Why?
HIV
1
2013
249
0.090
Why?
Proteome
1
2016
520
0.090
Why?
Coinfection
1
2013
143
0.090
Why?
Child
7
2024
22693
0.080
Why?
Reproducibility of Results
2
2023
3416
0.080
Why?
Dopamine Uptake Inhibitors
1
2011
59
0.080
Why?
Infant, Newborn
3
2016
6460
0.080
Why?
Down Syndrome
1
2016
529
0.080
Why?
Cocaine-Related Disorders
1
2011
132
0.070
Why?
Proteomics
1
2016
1203
0.070
Why?
Adjuvants, Immunologic
1
2011
245
0.070
Why?
Clinical Competence
1
2018
1272
0.070
Why?
Escherichia coli
2
2004
832
0.070
Why?
Pregnancy
3
2016
7230
0.070
Why?
Education, Medical, Graduate
1
2014
568
0.070
Why?
United States
4
2016
16136
0.070
Why?
Quality Control
1
2008
163
0.070
Why?
Comorbidity
1
2013
1665
0.070
Why?
Nucleic Acid Amplification Techniques
1
2008
39
0.070
Why?
Histocytochemistry
1
2008
77
0.070
Why?
Male
12
2025
73396
0.070
Why?
Predictive Value of Tests
1
2013
2113
0.060
Why?
Tuberculin Test
2
2018
36
0.060
Why?
Adolescent
5
2021
22557
0.060
Why?
Primary Health Care
1
2018
1776
0.060
Why?
Peripheral Vascular Diseases
1
2008
102
0.060
Why?
Young Adult
3
2021
14330
0.060
Why?
Protective Clothing
1
2006
15
0.060
Why?
Quality Improvement
1
2015
1354
0.060
Why?
Museums
1
2005
9
0.060
Why?
Periodicity
1
2025
57
0.060
Why?
Biomarkers
1
2016
4340
0.050
Why?
Haemophilus Infections
1
2024
45
0.050
Why?
Amoxicillin-Potassium Clavulanate Combination
1
2024
16
0.050
Why?
Bacterial Typing Techniques
1
2004
40
0.050
Why?
Enterobacteriaceae
1
2004
44
0.050
Why?
Species Specificity
1
2025
543
0.050
Why?
Case-Control Studies
2
2024
3647
0.050
Why?
beta-Lactamases
1
2024
54
0.050
Why?
Anti-Infective Agents, Urinary
1
2003
16
0.050
Why?
Bronchopneumonia
1
2003
6
0.050
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2003
43
0.050
Why?
Hospitals, Public
1
2003
30
0.050
Why?
Nasopharynx
1
2023
72
0.050
Why?
Mycobacterium Infections
1
2003
55
0.050
Why?
Multiplex Polymerase Chain Reaction
1
2023
56
0.050
Why?
Escherichia coli Infections
1
2003
125
0.050
Why?
Chorioamnionitis
1
2003
50
0.050
Why?
Ghana
1
2022
43
0.050
Why?
Pneumonia, Pneumocystis
1
2002
34
0.050
Why?
Mycoses
1
2003
87
0.050
Why?
Colorado
4
2018
4595
0.050
Why?
Granuloma
1
2002
96
0.040
Why?
HIV Seropositivity
1
2002
118
0.040
Why?
Streptococcus pneumoniae
1
2023
187
0.040
Why?
Fetal Diseases
1
2003
192
0.040
Why?
Neisseria gonorrhoeae
1
2021
29
0.040
Why?
Bacterial Infections
1
2003
247
0.040
Why?
Middle Aged
4
2018
36619
0.040
Why?
Antiretroviral Therapy, Highly Active
1
2002
278
0.040
Why?
Chlamydia trachomatis
1
2021
49
0.040
Why?
Urban Health
1
2021
95
0.040
Why?
Virus Diseases
1
2003
219
0.040
Why?
Risk Factors
3
2018
10921
0.040
Why?
Prevalence
2
2021
2861
0.040
Why?
Retrospective Studies
4
2021
17438
0.040
Why?
Phylogeography
1
2019
52
0.040
Why?
Homosexuality, Male
1
2021
231
0.040
Why?
Ecology
1
2019
106
0.040
Why?
Telepathology
1
2018
4
0.030
Why?
Emergency Service, Hospital
1
2010
2363
0.030
Why?
Models, Animal
1
2019
387
0.030
Why?
Bacteria
1
2023
766
0.030
Why?
Morbidity
1
2018
319
0.030
Why?
Pregnancy, Triplet
1
2016
5
0.030
Why?
Enzyme-Linked Immunospot Assay
1
2016
40
0.030
Why?
Animals
4
2025
38107
0.030
Why?
Twins, Monozygotic
1
2016
133
0.030
Why?
Lung Diseases
1
2002
787
0.030
Why?
Time
1
2015
85
0.030
Why?
Drug Resistance, Microbial
1
2015
67
0.030
Why?
HIV Infections
1
2010
3215
0.030
Why?
Asia
1
2014
69
0.030
Why?
Emigrants and Immigrants
1
2016
160
0.020
Why?
Safety Management
1
2015
130
0.020
Why?
Program Development
1
2015
371
0.020
Why?
Research
1
2015
421
0.020
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2011
8
0.020
Why?
False Negative Reactions
1
2011
61
0.020
Why?
Leukoencephalopathies
1
2011
23
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2011
124
0.020
Why?
Crack Cocaine
1
2010
9
0.020
Why?
Hospitals, Urban
1
2011
140
0.020
Why?
Program Evaluation
1
2015
952
0.020
Why?
Leukopenia
1
2010
33
0.020
Why?
Evolution, Molecular
1
2014
502
0.020
Why?
Phylogeny
1
2014
924
0.020
Why?
Leukocyte Count
1
2010
321
0.020
Why?
Neutropenia
1
2010
153
0.020
Why?
Treatment Outcome
1
2024
11821
0.020
Why?
Informed Consent
1
2010
195
0.020
Why?
Aging
1
2019
1996
0.020
Why?
Follow-Up Studies
1
2018
5439
0.020
Why?
Bone Marrow
1
2010
310
0.020
Why?
Cognition
1
2015
1292
0.010
Why?
Patient Compliance
1
2010
589
0.010
Why?
Molecular Epidemiology
1
2003
74
0.010
Why?
Community-Acquired Infections
1
2003
179
0.010
Why?
Prospective Studies
1
2003
8123
0.010
Why?
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)